查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847720

血液处理设备及耗材市场（依产品类型、技术、应用、最终用户及通路划分）－2025-2032年全球预测

Blood Processing Devices & Consumables Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血液处理设备和耗材市场规模将达到 1,166 亿美元，复合年增长率为 10.88%。

主要市场统计数据
基准年 2024 510.2亿美元
预计年份：2025年 566.4亿美元
预测年份：2032年 1166亿美元
复合年增长率 (%) 10.88%

建构一个全面的框架，阐述影响血液处理设备和耗材未来应用的临床、技术、监管和营运动态。

血液处理设备和耗材领域正经历临床需求、技术创新和日益严格的监管要求三者交汇的演变。医疗机构、实验室主任和采购团队面临着不断变化的环境，设备性能、耗材品质和工作流程整合决定临床可靠性和营运效率。本执行摘要概述了对血液采集、分离、检测和储存环节的决策者而言最重要的驱动因素和实际影响。

在临床环境中，需求讯号日益受到平衡吞吐量和安全性的需求所驱动。自动化处理和病原体灭活技术的创新旨在降低变异性并提高安全性，而耗材设计的进步则旨在简化操作并延长保质期。同时，监管审查和合规框架正在推动製造商和最终用户之间更紧密的合作，重点关注可追溯性、验证通讯协定和上市后监测。这些因素的汇聚促使各组织在采购和采用技术时优先考虑互通性、供应链韧性和生命週期支援。

本文所采用的组装旨在阐明技术能力、以使用者为中心的设计以及政策驱动因素如何塑造一个更加一体化、以品质为导向的市场，从而为后续分析奠定基础。此外，它还提供了一个视角，用于审视市场区隔、区域动态、关税影响和竞争定位，并为临床、实验室和研究领域的相关人员提供切实可行的观点。

自动化、病原体缓解创新和整合生命週期支援如何重新定义临床血液处理中的采购优先事项和营运模式

随着自动化技术的成熟、病原体控制技术的进步以及数据主导的品质保证日益融入工作流程，血液处理生态系统正在经历一场变革。自动化处理平台正从实验性部署走向高通量处理中心的主流应用，改变了手动操作的角色，并重新定义了人员配置模式。随着这些平台规模的扩大，人们的关注点正从服务点效能转向系统互通性和全生命週期总拥有成本，从而推动了新的采购标准和供应商服务期望的出台。

同时，病原体灭活系统和先进诊断技术的进步提高了安全性标准，同时也刺激了对相容耗材和检验的处理通讯协定的需求。这些技术进步与改进的储存和运输设备相辅相成，延长了保质期并提高了温度控制精度，从而拓宽了血站和医院的物流选择。所有这些因素累积促成了一个市场趋势：模组化、适应性强的解决方案更受青睐，能够整合到不同的临床流程中。

在营运方面，终端用户重视可追溯性、即时品质指标和简化的使用者介面，以减轻培训负担并减少操作错误。分销模式也不断演变：对于复杂的设备，直销关係依然存在；而对于标准化耗材和替换零件，经销商和电子商务通路的重要性日益凸显。这些转变正在创造一个更互联、以效率为导向的环境，这将使那些能够将强大的工程技术、快速反应的支援和检验的临床工作流程相结合的製造商获得丰厚的回报。

关税主导的供应链重组和采购韧性：透过策略重组采购、在地化生产和多元化高效供应商

美国近期加征的关税为製造商、经销商和终端用户带来了新的考量，不仅影响直接成本，也影响供应链结构、筹资策略和供应商选择。关税带来的价格压力促使企业重新评估零件采购，尽可能实现在地化生产，并实现供应商多元化以降低风险敞口。虽然这些策略调整短期内会增加复杂性，但从长远来看，它们也会加速对本地製造和合格替代供应管道的投资。

对于医疗设备和耗材製造商而言，关税正在影响其最终组装的选择以及如何建立供应商合约以在确保合规性的同时保障净利率。终端使用者和采购团队正在透过扩大供应商资格认证范围、纳入更多供应商以及协商能够应对前置作业时间延长的服务和保固条款来应对这项挑战。在调整采购策略的同时，企业也更加重视库存管理，包括采取缓衝库存措施和准确的需求预测，以降低关税导致的供应波动对业务中断的风险。

监管管道和检验要求可能会使快速更换供应商变得复杂，尤其对于抗凝血剂、过滤器和血袋等关键耗材而言。因此，各组织需要在成本控制和检验流程的连续性之间寻求平衡。总而言之，关税环境正促使整个价值链朝着更谨慎、注重韧性的方向发展，强调供应商冗余、在地化能力和严格的变更控制机制。

将产品类别、自动化模式、临床应用、使用者画像和分销管道与策略需求连结起来的详细細項分析

细緻的细分观点揭示了价值与风险在产品类型、技术、应用、最终用户和分销管道中的交汇点。耗材包括抗凝血剂和添加剂、血袋和输血器、过滤器和检测套组，而设备则包括血浆分离机、离心机、病原体灭活系统和储存设备。每类产品都有不同的监管管道、耗材生命週期要求和使用者培训要求，这些都会影响产品的普及速度和服务模式。

技术细分区分了自动化处理和手动处理，凸显了全自动系统在高效能环境中的重要性日益增长，以及半自动化系统在资源受限环境中的重要性日益增长。这种技术上的二分法导致不同临床环境的支出模式和整合需求存在差异：自动化解决方案着重于软体整合、资料管理和供应商支援的维护，而手动流程则高度依赖耗材标准化和使用者能力。

血液采集、成分分离、诊断检测、病原体去除以及储存/运输等不同应用场景下的差异，导致了性能指标和检验查核点的多样性。包括血库、诊断实验室、医院诊所和研究机构在内的终端用户，其优先事项也各不相同。在血库中，供应的连续性和合规性至关重要；在实验室中，诊断准确性和通量是选择指南；在医院中，临床适用性和床边人体工学设计至关重要；而在研究环境中，灵活性和实验控制是重中之重。分销管道涵盖了从复杂设备的直接销售到分销商和耗材的电子商务，这些管道影响着前置作业时间、服务模式和价格透明度。这些细分洞察凸显了产品开发、商业策略和售后支援必须与每个使用者群体和技术类别的具体需求相符的重要性。

对美洲、中东和非洲以及亚太地区的监管复杂性、基础设施多样性和分销重要性进行比较评估

美洲、中东和非洲以及亚太地区的区域动态差异显着，不同的监管、报销和基础设施环境会影响招募管道和供应商策略。在美洲，采购和临床网路通常强调规模和整合，倾向于采用整合解决方案和服务包，以降低大型中心的营运复杂性。该地区的法规结构支援既定的检验流程，物流网路通常也便于集中配送设备和耗材。

中东和非洲的医疗保健体系千差万别，部分地区的市场准入受到严格的监管标准约束，而另一些地区则面临基础设施不足的限制。这种多样性为产品设计提供了机会，使其能够适应资源丰富和资源匮乏的环境。在该地区运作的相关人员经常需要应对跨境监管协调、不同的报销规则以及维持临床连续性所需的强大售后服务。

亚太地区既拥有成熟市场（具备先进的检测能力），也拥有快速发展的新兴市场（正在拓展血液服务）。本地製造业投资和贸易政策影响供应链决策，而终端用户往往寻求既经济高效又不影响安全性的解决方案。在整个全部区域，与本地经销商伙伴关係以及建立策略性的本地服务网络对于确保运作和符合监管要求至关重要。这些区域性洞察共同指导供应商如何调整打入市场策略、支援模式和产品组合，以适应当地的临床和营运实际情况。

竞争动态和策略定位强调临床检验、整合服务网络和有针对性的伙伴关係关係，以拓展产品组合。

竞争动态的核心在于成熟的医疗设备製造商、专业耗材製造商以及提供新型自动化或诊断技术的参与企业企业。领先企业透过结合检验的临床表现、完善的服务体係以及提供可互通的解决方案的能力来脱颖而出，这些解决方案能够相容于不同的实验室资讯系统和医院工作流程。对于那些希望伙伴关係其在器械和耗材领域产品组合，同时弥补病原体灭活、自动化和低温运输解决方案方面能力缺口的企业而言，策略合作和有针对性的收购是常见的策略。

成熟的公司通常利用全球服务网路和延长保固期来支援大型血站和医院系统采用其产品，而创新型挑战者则在模组化、更低的初始成本和软体驱动的工作流程效率方面展开竞争。拥有直销团队负责复杂设备部署的公司通常会签订长期服务协议，而那些利用经销商关係和电子商务管道的公司则强调可扩展性和耗材的快速补充。

市场参与企业正日益增加对证据产生的投入，包括临床检验和真实世界表现测试，以支持采购决策和报销谈判。这种对临床可靠性的投入，加上可证明的总体拥有成本优势和强大的客户支持，对于赢得机构合约以及与临床、实验室和研究终端用户签订长期特许权使用费至关重要。

领导者需采取切实可行的营运和商业措施，以平衡创新、供应链韧性和以客户为中心的全生命週期支援。

产业领导者应优先考虑协作方式，在创新、供应链韧性和以使用者为中心的设计之间取得平衡。製造商必须投资于模组化自动化平台，这些平台可根据不同的吞吐量需求进行配置，同时确保与各种耗材相容，从而减少客户切换过程中的摩擦。同时，对完善的售后服务、远距离诊断和软体更新进行投资，可以保障运作并维持长期的客户关係。

供应链策略应强调合格的多供应商采购、区域组装能力以及能够降低贸易中断风险的库存管理实务。营运团队应建立规范的变更管理管道，以加快替代供应商的资格认证，同时确保不影响验证要求。商务团队应采用反映全生命週期成本（而不仅仅是单位成本）的合约模式，并将奖励与服务绩效、耗材供应和临床结果相结合。

最后，领导者应积极与监管机构、标准组织和临床相关人员合作，为新技术（特别是病原体灭活和高度自动化系统）制定切实可行的验证框架。投资于可操作证据的产生、临床医生培训项目和可互通的数据标准，将加速新技术的应用，并降低医院、血库和实验室采购决策的风险。

此方法框架结合了关键相关人员的洞察、监管环境分析和供应商概况，以产生可操作且检验的市场情报。

本研究整合了一手和二手资料，旨在建立基于实证的血液处理设备和耗材市场格局图景。一手资料包括对临床医生、实验室主任、采购专业人员和技术负责人的结构化访谈，并辅以设备和耗材的生命週期文件、临床检验报告和监管申报文件。二手资料包括同行评审的临床文献、技术标准和政策出版刊物，这些资料为产品性能声明和市场推广驱动因素提供了背景资讯。

我们的分析方法结合了相关人员访谈的质性主题编码和产品及供应商对比分析，以识别设计、可用性和服务模式方面的差异化因素。我们将监管管道和检验要求与产品类别进行匹配，以识别推广障碍。我们的供应链分析考虑了组件采购、生产布局和分销模式，而风险评估则评估了关税、前置作业时间波动和单一来源依赖性的影响。在整个方法论过程中，我们专注于确保其稳健性，并对采购、调查方法和资料来源进行三角验证，以揭示对采购、调查方法、资料来源和商业策略的实际意义。

一项强调检验的绩效、灵活的服务模式和稳健的采购的综合策略要务，旨在确保长期的临床和商业性成功。

整体而言，成功的新参与企业和现有企业必须具备以下条件：拥有检验的临床记录、适应性强、以服务为导向的经营模式以及稳健的供应链。自动化和病原体灭活的技术进步能够带来显着的临床和营运效益，但其应用取决于可验证的互通性、简化的检验管道以及强大的售后支援。耗材的品质和相容性仍然是保障安全性和工作流程效率的基础，因此设备製造商和耗材供应商之间的密切合作至关重要。

区域和监管差异要求采取独特的市场进入策略，重点在于本地服务能力和证据生成，以支持采购决策。不断变化的关税环境和贸易政策加大了采购多元化的压力，并促使企业尽可能投资于本地製造和组装。最终，市场将奖励那些能够提供可预测结果、降低临床团队工作复杂性并提供透明的全生命週期价值的供应商。优先考虑这些因素的相关人员将能够在应对经济和政策逆风的同时，满足不断变化的临床需求。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 提高血小板和血浆安全病原体减少技术的应用
  • 将人工智慧和预测分析整合到血液处理工作流程中
  • 开发封闭式血液采集和处理试剂套件，以最大限度降低污染风险
  • 具备高通量多组分采集能力的先进分析系统快速发展
  • 增加血浆分馏用一次性耗材，以提高规模化生产能力并减少交叉污染
  • 扩大移动式和照护现场血液分离装置的规模，以应对偏远地区和紧急情况
  • 一种相容于多种抗凝血剂和无抗凝血剂方法的通用血液处理平台的出现
  • 监管机构强调标准化安全通讯协定，并鼓励采用自动血液离心机。
  • 增加对基于微流体的诊断投资，以实现快速现场血液成分分析和品质保证

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的血液处理设备和耗材市场

  • 消耗品
    • 抗凝血剂和添加剂
    • 血袋和套装
    • 筛选
    • 检测套组
  • 装置
    • 血液分离机
    • 离心机
    • 病原体减少系统
    • 储存装置

9. 按技术分類的血液处理设备及耗材市场

  • 自动处理
    • 全自动系统
    • 半自动系统
  • 手动处理

第十章 依应用分類的血液处理设备及耗材市场

  • 血液收集
  • 组分分离
  • 诊断测试
  • 病原体清除
  • 仓储和运输

第十一章 依最终用户分類的血液处理设备和耗材市场

  • 血库
  • 诊断实验室
  • 医院和诊所
  • 研究所

第十二章：血液处理设备及耗材市场（依通路划分）

  • 直销
  • 经销商
  • 电子商务

第十三章：血液处理设备及耗材市场区域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 血液处理设备及耗材市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国血液处理设备及耗材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Haemonetics Corporation
    • Terumo Corporation
    • Pall Corporation
    • Fresenius Kabi AG
    • Grifols, SA
    • Octapharma AG
    • Macopharma SA
    • GE Healthcare Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • Miltenyi BIoTec GmbH
Product Code: MRR-AB49FC1AB774

The Blood Processing Devices & Consumables Market is projected to grow by USD 116.60 billion at a CAGR of 10.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 51.02 billion
Estimated Year [2025] USD 56.64 billion
Forecast Year [2032] USD 116.60 billion
CAGR (%) 10.88%

Comprehensive framing of clinical, technological, regulatory, and operational dynamics shaping the future adoption of blood processing devices and consumables

The landscape for blood processing devices and consumables is evolving at the intersection of clinical need, technological innovation, and tightening regulatory expectations. Providers, laboratory directors, and procurement teams are navigating a shifting environment in which device performance, consumable quality, and workflow integration determine clinical reliability and operational efficiency. This executive summary synthesizes the thematic drivers and practical implications that matter most to decision-makers managing blood collection, separation, testing, and storage pathways.

Across clinical settings, demand signals are increasingly shaped by the need to balance throughput with safety. Innovations in automated processing and pathogen reduction aim to reduce variability and enhance safety, while consumable design advances seek to streamline handling and extend shelf life. At the same time, regulatory scrutiny and compliance frameworks are prompting closer alignment between manufacturers and end users, focusing on traceability, validation protocols, and postmarket surveillance. The convergence of these forces is leading organizations to prioritize interoperability, supply chain resilience, and lifecycle support during procurement and technology adoption.

This introduction frames the subsequent analysis by highlighting how technical performance, user-centric design, and policy drivers are creating a more integrated, quality-focused market. It also establishes the lens through which we examine segmentation, regional dynamics, tariff effects, and competitive positioning to surface actionable perspectives for stakeholders across clinical, laboratory, and research environments.

How automation, pathogen mitigation innovations, and integrated lifecycle support are redefining procurement priorities and operational models across clinical blood processing

The blood processing ecosystem is undergoing transformative shifts as automation matures, pathogen mitigation technologies advance, and data-driven quality assurance becomes increasingly embedded in workflows. Automated processing platforms are moving from experimental adoption to mainstream deployment in high-volume centers, which is altering the role of manual methods and redefining staffing models. As these platforms scale, attention shifts from single-function performance to system interoperability and lifecycle total cost of ownership, prompting new procurement criteria and vendor-service expectations.

Simultaneously, pathogen reduction systems and enhanced diagnostics are raising the bar for safety while stimulating demand for compatible consumables and validated processing protocols. These technological strides are complemented by improvements in storage and transport equipment that enable extended preservation windows and better temperature control, thereby expanding logistical options for blood centers and hospitals. The cumulative effect is a market that favors modular, adaptable solutions capable of integrating into diverse clinical pathways.

Operationally, end users are placing a premium on traceability, real-time quality metrics, and simplified user interfaces to lower training burdens and reduce handling errors. Distribution models are also evolving: direct sales relationships persist for complex instruments while distributors and e-commerce channels grow in importance for standardized consumables and replacement parts. Together, these shifts create a more connected, efficiency-oriented environment that rewards manufacturers who combine robust engineering with responsive support and validated clinical workflows.

Tariff-driven supply chain realignment and procurement resilience strategies that reshape sourcing, production localization, and validated supplier diversification

Recent tariff actions in the United States have introduced new considerations for manufacturers, distributors, and end users that extend beyond immediate cost implications to influence supply chain architecture, sourcing strategies, and vendor selection. Tariff-related pricing pressures incentivize companies to reassess component sourcing, regionalize production where feasible, and pursue supplier diversification to mitigate exposure. These strategic shifts can increase near-term complexity but also accelerate longer-term investments in local manufacturing and qualified alternative supply streams.

For manufacturers of both devices and consumables, tariffs influence decisions about where to base final assembly and how to structure supplier contracts to preserve margin while maintaining regulatory compliance. End users and procurement teams respond by expanding qualification processes to include additional suppliers and by negotiating service and warranty terms that account for longer lead times. Alongside procurement adjustments, there is a renewed emphasis on inventory management practices, including buffer stock policies and demand forecasting accuracy, to reduce risk of operational disruption during tariff-induced supply volatility.

Regulatory pathways and validation requirements can complicate rapid source substitutions, especially for critical consumables such as anticoagulants, filters, and blood bags. Consequently, organizations are balancing the trade-offs between cost containment and continuity of validated processes. In summary, the tariff environment is prompting a more deliberate, resilience-focused orientation across the value chain that emphasizes supplier redundancy, regional capacity, and rigorous change control mechanisms.

Deep segmentation analysis linking product classes, automation paradigms, clinical applications, user profiles, and distribution pathways to strategic imperatives

A nuanced segmentation view reveals where value and risk converge across product types, technologies, applications, end users, and distribution channels. Product-level differentiation separates consumables from devices, with consumables encompassing anticoagulants and additives, blood bags and sets, filters, and test kits, while devices cover apheresis machines, centrifuges, pathogen reduction systems, and storage equipment. Each product class carries distinct regulatory pathways, consumable lifecycle demands, and user training requirements that influence adoption cadence and service models.

Technology segmentation distinguishes automated processing from manual processing, highlighting the growing relevance of fully automated systems and semi-automated systems in high-throughput and resource-constrained settings respectively. This technological bifurcation drives varied spending patterns and integration needs across clinical environments, with automated solutions emphasizing software integration, data management, and vendor-supported maintenance, while manual processes depend more heavily on consumable standardization and user competency.

Application-based differences, spanning blood collection, component separation, diagnostic testing, pathogen reduction, and storage and transportation, create divergent performance metrics and validation checkpoints. End users such as blood banks, diagnostic laboratories, hospitals and clinics, and research institutes impose different priorities: supply continuity and regulatory compliance dominate in blood banks, diagnostic precision and throughput guide laboratory choices, clinical compatibility and bedside ergonomics matter in hospitals, and flexibility and experimental control are paramount in research settings. Distribution channels range from direct sales for complex instrumentation to distributors and e-commerce for consumables, shaping lead times, service models, and price transparency. These segmentation insights underscore the importance of aligning product development, commercial strategy, and post-sale support with the specific needs of each user cohort and technology class.

Comparative regional assessment of regulatory complexity, infrastructure variability, and distribution imperatives across the Americas, Europe Middle East and Africa, and Asia Pacific

Regional dynamics vary meaningfully across the Americas, Europe Middle East and Africa, and Asia Pacific, each presenting distinct regulatory, reimbursement, and infrastructure landscapes that influence adoption pathways and supplier strategies. In the Americas, procurement and clinical networks often emphasize scale and consolidation, which favors integrated solutions and service bundles that reduce operational complexity in high-volume centers. Regulatory frameworks in this region support established validation processes, and logistic networks generally facilitate centralized distribution for both devices and consumables.

Europe Middle East and Africa comprises a heterogeneous set of health systems where market access is influenced by stringent regulatory standards in some jurisdictions and constrained infrastructure in others. This diversity creates opportunities for adaptable product designs that can be configured for both resource-rich and resource-limited settings. Stakeholders operating in this region frequently must navigate cross-border regulatory harmonization, varied reimbursement rules, and the need for strong after-sales service to maintain clinical continuity.

Asia Pacific includes mature markets with advanced laboratory capabilities alongside rapidly developing healthcare systems that are scaling blood services. Local manufacturing investments and trade policies influence supply chain decisions, and end users often seek cost-effective solutions that do not compromise safety. Across the region, partnerships with regional distributors and strategic local service networks are essential to ensure uptime and regulatory compliance. Collectively, these regional insights inform how vendors should tailor market entry strategies, support models, and product configurations to align with local clinical and operational realities.

Competitive dynamics and strategic positioning that emphasize clinical validation, integrated service networks, and targeted partnerships to strengthen portfolio breadth

Competitive dynamics center on a mix of established medical device manufacturers, specialist consumable producers, and emerging technology entrants that offer novel automation or diagnostic capabilities. Leading players differentiate through a combination of validated clinical performance, comprehensive service ecosystems, and the ability to provide interoperable solutions that fit into diverse laboratory information systems and hospital workflows. Strategic partnerships and targeted acquisitions have been common tactics for firms seeking to broaden portfolios across both devices and consumables while closing capability gaps in pathogen reduction, automation, and cold chain solutions.

Mature companies typically leverage global service networks and extended warranties to support adoption in large-scale blood centers and hospital systems, whereas innovative challengers compete on modularity, lower upfront cost, and software-enabled workflow efficiencies. Distribution approaches also create competitive separation: organizations that maintain direct sales teams for complex instrument placements often embed long-term service agreements, while those that capitalize on distributor relationships or e-commerce channels emphasize scalability and rapid replenishment for consumables.

Market participants are increasingly investing in evidence generation, including clinical validations and real-world performance studies, to support procurement decisions and reimbursement discussions. This investment in clinical credibility, combined with demonstrable cost of ownership advantages and strong customer support, is central to winning both institutional contracts and long-term loyalty across clinical, laboratory, and research end users.

Actionable operational and commercial imperatives for leaders to balance innovation, supply chain resilience, and customer-centric lifecycle support

Industry leaders should prioritize a coordinated approach that balances innovation with supply chain resilience and user-centered design. Manufacturers must invest in modular automation platforms that can be configured across different throughput profiles, while ensuring compatibility with a broad range of consumables to reduce switching friction for customers. Parallel investments in robust post-sale service, remote diagnostics, and software updates will protect uptime and maintain long-term customer relationships.

Supply chain strategies should focus on qualified multi-sourcing, regional assembly capabilities, and inventory policies that reduce exposure to trade disruptions. Operational teams ought to formalize change control pathways that accelerate qualification of alternate suppliers without compromising validation requirements. Commercial teams should adapt contracting approaches to reflect total lifecycle costs rather than unit pricing alone, aligning incentives for service performance, consumable availability, and clinical outcomes.

Finally, leaders should engage proactively with regulators, standards bodies, and clinical stakeholders to shape pragmatic validation frameworks for new technologies, particularly pathogen reduction and highly automated systems. Investing in pragmatic evidence generation, clinician training programs, and interoperable data standards will accelerate adoption and de-risk procurement decisions for hospitals, blood banks, and laboratories.

Methodological framework blending primary stakeholder insights, regulatory mapping, and supplier profiling to produce pragmatic, verifiable market intelligence

This research synthesizes primary and secondary intelligence to develop an evidence-based view of the blood processing devices and consumables landscape. Primary inputs include structured interviews with clinicians, laboratory directors, procurement specialists, and technology leaders, complemented by device and consumable lifecycle documentation, clinical validation reports, and regulatory filings. Secondary inputs include peer-reviewed clinical literature, technical standards, and policy publications that contextualize product performance claims and adoption drivers.

The analytical approach combines qualitative thematic coding of stakeholder interviews with comparative product and supplier profiling to identify differentiators in design, usability, and service models. Regulatory pathways and validation requirements were mapped to product classes to clarify adoption barriers. Supply chain analysis considered component sourcing, manufacturing footprints, and distribution models, while risk assessments evaluated tariff impacts, lead time variability, and single-source dependencies. Throughout the methodology, emphasis was placed on triangulating multiple data sources to ensure robustness and to surface practical implications for procurement, R&D, and commercial strategy.

Synthesis of strategic imperatives emphasizing validated performance, adaptable service models, and resilient sourcing to secure long-term clinical and commercial success

The overarching conclusion is that successful entrants and incumbents will be those who combine validated clinical performance with adaptable, service-oriented business models and resilient supply chains. Technological advances in automation and pathogen reduction offer meaningful clinical and operational benefits, but their adoption depends on demonstrable interoperability, streamlined validation pathways, and strong post-sale support. Consumable quality and compatibility remain foundational to maintaining safety and workflow efficiency, making close collaboration between device manufacturers and consumable suppliers essential.

Regional and regulatory differences require tailored go-to-market approaches, with an emphasis on local service capabilities and evidence generation to support procurement decisions. Tariff environments and trade policy shifts add pressure to diversify sourcing and invest in regional manufacturing or assembly where feasible. Ultimately, the market rewards providers who deliver predictable outcomes, reduce complexity for clinical teams, and provide transparent total lifecycle value. Stakeholders that prioritize these imperatives will be better positioned to meet evolving clinical demands while navigating economic and policy headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of pathogen reduction technologies for platelet and plasma safety
  • 5.2. Integration of artificial intelligence and predictive analytics in blood processing workflows
  • 5.3. Development of closed-system blood collection and processing kits to minimize contamination risk
  • 5.4. Surge in advanced apheresis systems offering high-throughput multi-component collection capabilities
  • 5.5. Growth in single-use consumables for plasma fractionation to enhance scalability and reduce cross-contamination
  • 5.6. Expansion of mobile and point-of-care blood separation units for remote and emergency settings
  • 5.7. Emergence of universal blood processing platforms compatible with multiple anticoagulants and anticoagulant-free methods
  • 5.8. Regulatory emphasis on standardized safety protocols driving adoption of automated blood centrifugation devices
  • 5.9. Rising investment in microfluidic-based diagnostics for rapid on-site blood component analysis and quality assurance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Devices & Consumables Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Anticoagulants And Additives
    • 8.1.2. Blood Bags And Sets
    • 8.1.3. Filters
    • 8.1.4. Test Kits
  • 8.2. Devices
    • 8.2.1. Apheresis Machines
    • 8.2.2. Centrifuges
    • 8.2.3. Pathogen Reduction Systems
    • 8.2.4. Storage Equipment

9. Blood Processing Devices & Consumables Market, by Technology

  • 9.1. Automated Processing
    • 9.1.1. Fully Automated Systems
    • 9.1.2. Semi Automated Systems
  • 9.2. Manual Processing

10. Blood Processing Devices & Consumables Market, by Application

  • 10.1. Blood Collection
  • 10.2. Component Separation
  • 10.3. Diagnostic Testing
  • 10.4. Pathogen Reduction
  • 10.5. Storage And Transportation

11. Blood Processing Devices & Consumables Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals And Clinics
  • 11.4. Research Institutes

12. Blood Processing Devices & Consumables Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. E Commerce

13. Blood Processing Devices & Consumables Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Processing Devices & Consumables Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Processing Devices & Consumables Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Haemonetics Corporation
    • 16.3.2. Terumo Corporation
    • 16.3.3. Pall Corporation
    • 16.3.4. Fresenius Kabi AG
    • 16.3.5. Grifols, S.A.
    • 16.3.6. Octapharma AG
    • 16.3.7. Macopharma S.A.
    • 16.3.8. GE Healthcare Technologies Inc.
    • 16.3.9. Bio-Rad Laboratories, Inc.
    • 16.3.10. Miltenyi Biotec GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BLOOD PROCESSING DEVICES & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY ANTICOAGULANTS AND ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BAGS AND SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PATHOGEN REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY STORAGE AND TRANSPORTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATED PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BLOOD PROCESSING DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY,